Psychology & Intimacy GLP-1 Receptor Agonists Show Promising Mental Health Benefits in Large-Scale Study May 19, 2026 Rebecca Shoemaker A groundbreaking study involving nearly 100,000 individuals has revealed that medications commonly prescribed for type 2 diabetes and obesity, such as Ozempic and Wegovy, may offer significant and unexpected benefits…
Psychology & Intimacy A Promising New Avenue for Alzheimer’s Treatment Emerges from Hydrogen Sulfide Research May 17, 2026 Rebecca Shoemaker Researchers at Johns Hopkins Medicine are making significant strides in the fight against Alzheimer’s disease, thanks to a newly funded study from the National Institutes of Health. This groundbreaking research…
Human Sexuality Research & Journals Infusing Creativity into a College Course: A Pilot Study Reveals Promising Results for Student Engagement and Mindset May 14, 2026 Lina Irawan Creativity, long considered a vital yet often overlooked skill in higher education, is gaining significant traction among both educators and employers. Despite its increasing importance, the integration of creativity into…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study May 10, 2026 Rebecca Shoemaker New research indicates that glucagon-like peptide-1 (GLP-1) receptor agonists, a class of drugs widely used for managing type 2 diabetes and obesity, may also offer significant benefits for mental well-being.…
Psychology & Intimacy A Novel Protein Pathway Emerges as a Promising Target for Alzheimer’s Disease Treatment May 2, 2026 Rebecca Shoemaker Researchers at Johns Hopkins Medicine are embarking on a new frontier in the fight against Alzheimer’s disease, fueled by a substantial grant from the National Institutes of Health (NIH). This…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Promising Oral Solution in the Global Battle Against Drug-Resistant Gonorrhea April 28, 2026 Susilo Ahmad Researchers are heralding a significant advancement in the fight against gonorrhea, a pervasive sexually transmitted infection, with the development of a novel oral medication named zoliflodacin. This investigational drug holds…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health, Reducing Psychiatric Hospitalizations and Work Absences April 28, 2026 Rebecca Shoemaker New, large-scale research involving nearly 100,000 individuals has unveiled a significant correlation between the use of glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide (marketed as Ozempic, Wegovy, and Rybelsus),…
Sexual Health & Medical Wellness Zoliflodacin Offers New Hope in the Global Fight Against Drug-Resistant Gonorrhea with Promising Phase 3 Trial Results. April 21, 2026 Susilo Ahmad A significant breakthrough in the treatment of gonorrhea, one of the world’s most prevalent and increasingly drug-resistant sexually transmitted infections (STIs), has emerged with the successful conclusion of a late-stage…
Sexual Health & Medical Wellness Innovative Intranasal Vaccine Offers Promising Defense Against Evolving H5N1 Bird Flu Threat, Bolstering Pandemic Preparedness April 19, 2026 Susilo Ahmad H5N1 avian influenza, commonly known as bird flu, presents an escalating global health concern, with scientists at Washington University School of Medicine in St. Louis now unveiling a significant advancement…
Psychology & Intimacy GLP-1 Medications Show Promising Links to Improved Mental Health Outcomes in Large-Scale Study April 13, 2026 Rebecca Shoemaker New research spearheaded by an international consortium of scientists is shedding light on a potential, and perhaps unexpected, benefit of GLP-1 receptor agonists, a class of medications widely recognized for…
